PMID: 68765Jan 1, 1977Paper

Serological relationships between rotaviruses from different species as studied by complement fixation and neutralization

Archives of Virology
M E ThoulessJ A Herring


Human, piglet, mouse, foal, lamb, calf and rabbit rotaviruses all infected, but could not readily be subcultured in LLC MK2 cells. Cells infected with mouse and calf rotaviruses reacted by indirect immunofluorescence (FA) with convalescent serum from children, piglets, mice, foals, lambs, calves or rabbits, taken after rotavirus infection. Human, calf, piglet, mouse and foal rotaviruses reacted with human, calf, mouse, foal and lamb convalescent serum by complement fixation (CF). It was not possible to distinguish between different rotaviruses by CF or FA. Neutralization tests, however, detected species-specific rotavirus antigens. Any virus was neutralized by a much higher dilution of homologous species convalescent serum than by any heterologous serum. With the exception of the mouse virus there was very little cross reaction. However, in sera with a very high neutralizing titre for the homologous virus the titre was proportionately raised against heterologous virus. It is, therefore, now possible to type to species an unknown rotavirus by a neutralization test in LLC MK2 cells using convalescent serum from each species.


Oct 25, 1975·Lancet·J E BanatvalaG N Woode
Jan 1, 1976·The Journal of Infectious Diseases·A Torres-MedinaA Z Kapikian
Dec 18, 1975·Nature·J F NewmanG N Woode
May 1, 1976·The Journal of General Virology·J C Bridger, G N Woode
May 1, 1976·Journal of Medical Microbiology·G N WoodeG Jackson
Oct 16, 1976·The Veterinary Record·A S BrydenT H Flewett
Feb 1, 1977·Journal of Medical Microbiology·A S BrydenT H Flewitt
Nov 1, 1975·Journal of Medical Microbiology·J C BridgerH Davies
Oct 1, 1972·The Journal of General Virology·H J Els, G Lecatsas
Dec 29, 1973·Lancet·T H FlewettH Davies
Dec 1, 1972·Infection and Immunity·D H Much, I Zajac

❮ Previous
Next ❯


Jan 1, 1984·Archives of Virology·C K OjehA J Herring
Jan 1, 1981·Archives of Virology·J A ShirleyT H Flewett
Jan 1, 1982·Archives of Virology·K SatoM Matumoto
Jan 1, 1978·Archives of Virology·T H Flewett, G N Woode
Jan 1, 1982·Archives of Virology·M E ThoulessT H Flewett
Jan 1, 1979·Archives of Virology·M S McNultyJ B McFerran
Mar 13, 1979·Medical Microbiology and Immunology·L Brade, W A Schmidt
Dec 1, 1981·Veterinary Research Communications·M A ShalabyR M El-Karamany
Jan 1, 1986·Transactions of the Royal Society of Tropical Medicine and Hygiene·A C LinharesY B Gabbay
Jan 1, 1988·Comparative Immunology, Microbiology and Infectious Diseases·G CastrucciV Aldrovandi
Jun 1, 1988·Epidemiology and Infection·N MinamotoY Suzuki
Feb 12, 1981·The New England Journal of Medicine·N R Blacklow, G Cukor
Jan 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·H B GreenbergR M Chanock
May 11, 1984·Nucleic Acids Research·M L Dyall-Smith, I H Holmes
Nov 26, 1977·British Medical Journal·M E ThoulessT H Flewett
Jan 1, 1989·Clinical Microbiology Reviews·M L Christensen
Nov 17, 1978·Medical Microbiology and Immunology·J Kurtz, T Lee
Jan 1, 1982·Journal of Medical Virology·B M TotterdellJ E Banatvala
Apr 1, 1980·The Journal of Pediatrics·M C Steinhoff
Aug 4, 2015·Journal of Virological Methods·Peter H OttoMandy C Elschner
Dec 1, 1982·Pediatric Annals·L K PickeringS A Plotkin
Sep 1, 1979·Zentralblatt für Veterinärmedizin. Reihe B. Journal of veterinary medicine. Series B·P Debouck, M Pensaert
Feb 1, 1980·Acta Pathologica Et Microbiologica Scandinavica. Section C, Immunology·A B Otnaess, I Orstavik
Nov 1, 1977·Journal of Clinical Microbiology·D J Ellens, P W de Leeuw
Feb 1, 1988·Journal of Clinical Microbiology·H S Nagesha, I H Holmes
Aug 1, 1983·Journal of Clinical Microbiology·R G WyattA Z Kapikian
Sep 1, 1983·Journal of Clinical Microbiology·Y HoshinoA Z Kapikian
Mar 1, 1983·Journal of Virology·S SonzaI H Holmes
Aug 1, 1984·Journal of Clinical Microbiology·P A OffitS A Plotkin

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.